http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-112013016982-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e4d121c7abfaaeb49b0e383527ade50a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4196
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D249-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D249-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4196
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D249-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
filingDate 2011-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e43252aa82f702ce2094ba7184eeae6f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd0174a8c5e5d6ab31c07f21cf74f19c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de68ab70b5e2d44ea5a0e3f6ce62a42c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e360e61cf54825a92650514ce8fe4a7
publicationDate 2016-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-112013016982-A2
titleOfInvention 2- (5-bromo-4- (4-cyclopropylnaphthalen-1-yl) -4h-1,2,4-triazol-3-ylthio) acetic acid polymorphic forms and uses thereof
abstract polymorphic forms of 2- (5-bromo-4- (4-cyclopropylnaphthalen-1-yl) -4h-1,2,4-triazol-3-ylthio) acetic acid and uses thereof are described crystalline polymorphic forms of 2- (5-Bromo-4- (4-cyclopropylnaphthalen-1-yl) -4h-1,2,4-triazol-3-ylthio) acetic acid. Also disclosed are pharmaceutical compositions and the uses of such compounds, compound forms and compositions for treating various diseases and conditions.
priorityDate 2010-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420859410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53465279

Total number of triples: 30.